Which men should undergo non-targeted systematic sampling in an mpMRI-targeted pathway – an analysis from 1,719 pre-biopsy mpMRI cases?

Which men should undergo non-targeted systematic sampling in an mpMRI-targeted pathway – an analysis from 1,719 pre-biopsy mpMRI cases?

Bibliographic Details
Main Authors:	M.J. Connor, D. Eldred-Evans, F. Hosking-Jervis, E. Bass, D. Reddy, M. Bertoncelli Tanaka, H. Bhola-Stewart, W. Maynard, C. Khoo, T.T. Shah, J. Lee, D. Sri, L. Powell, S. Ahmad, M. Noureldin, S. Joshi, E. Pegers, K. Wong, H. Tam, D. Hrouda, M. Winkler, S. Gordon, H. Qazi, H.U. Ahmed
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320326744

Similar Items

Indeterminate mpMRI lesions: Evaluating the optimal PSA density threshold for prostate biopsy
by: D.T. Reddy, et al.
Published: (2020-07-01)

The RAPID risk model: A novel risk score to predict significant prostate cancer in men with an mpMRI lesion
by: D. Eldred-Evans, et al.
Published: (2020-07-01)

Mischievous malakoplakia: A potential pitfall of mpMRI of the prostate?
by: Michael E. Rezaee, et al.
Published: (2020-09-01)

Which prostate cancers are overlooked by mpMRI? An analysis from PROMIS
by: J. Norris, et al.
Published: (2020-07-01)

Added value of risk calculators to mpMRI in the diagnosis of prostate cancer
by: J.R. Gonçalves Correia, et al.
Published: (2020-07-01)

Applications of Artificial Intelligence to Prostate Multiparametric MRI (mpMRI): Current and Emerging Trends
by: Michelle D. Bardis, et al.
Published: (2020-05-01)

Accuracy of mpMRI in detecting lesion location in prostate cancer-inital experience
by: M. Parameswaran, et al.
Published: (2020-11-01)

Correlation between Gleason score and PIRADS score on mpMRI –initial experience
by: M. Parameswaran, et al.
Published: (2020-11-01)

Analisys of contralateral prostatic cancer odds in patients with monolateral lesions at mpMRI
by: A. Iseppi, et al.
Published: (2020-01-01)

Analysis of the cause of missed diagnosis in mpMRI/TRUS fusion-guided targeted prostate biopsy
by: Fan Zhang, et al.
Published: (2022-05-01)

bpMRI and mpMRI for detecting prostate cancer: A retrospective cohort study
by: Yongsheng Pan, et al.
Published: (2023-01-01)

Prostate mpMRI and MRI-Targeted Biopsy: State-of-the-art Protocol + PI-RADS v2.1
by: Pieter De Visschere, et al.
Published: (2019-11-01)

The combined value of mpUS and mpMRI-TRUS fusion for the diagnosis of clinically significant prostate cancer
by: Xin Zhang, et al.
Published: (2022-10-01)

Comparison between biparametric prostate MRI (bpMRI) and multiparametric MRI (mpMRI) in the detection of prostate cancer
by: A. Iseppi, et al.
Published: (2020-01-01)

Comparing Micro-Ultrasound to mpMRI in Detecting Clinically Significant Prostate Cancer
by: Christian Pavlovich, et al.
Published: (2022-02-01)

Differential diagnosis of uncommon prostate diseases: combining mpMRI and clinical information
by: Chao Han, et al.
Published: (2021-06-01)

mpMRI-visible prostate cancer is enriched with genomic hallmarks of poor prognosis: A bioinformatic analysis
by: J. Norris, et al.
Published: (2020-07-01)

Replacing TURBT with mpMRI for staging MIBC: Pilot data from the BladderPath trial
by: R.T. Bryan, et al.
Published: (2020-07-01)

Diagnostic performance of micro-ultrasound prostate biopsies in patients undergoing mpMRI-fusion biopsies
by: D. Maffei, et al.
Published: (2020-07-01)

Transperineal free-hand mpMRI targeted prostate biopsies under local anesthesia: A preliminary analysis of learning curves
by: G. Calleris, et al.
Published: (2020-07-01)

Targeted prostate biopsy: 68Ga-PSMA PET/CT vs. mpMRI in the diagnosis of prostate cancer
by: Pietro Pepe, et al.
Published: (2022-09-01)

Transrectal Ultrasound in Prostate Cancer: Current Utilization, Integration with mpMRI, HIFU and Other Emerging Applications
by: Panzone J, et al.
Published: (2022-03-01)

Clash of the calculators: External validation of prostate cancer risk calculators in men undergoing mpMRI and transperineal biopsy
by: G. Wei, et al.
Published: (2021-05-01)

Dynamic Contrast-Enhanced Study in the mpMRI of the Prostate—Unnecessary or Underutilised? A Narrative Review
by: Silva Guljaš, et al.
Published: (2023-11-01)

The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy
by: Łukasz Nyk, et al.
Published: (2021-05-01)

Transrectal ultrasound examination of prostate cancer guided by fusion imaging of multiparametric MRI and TRUS: avoiding unnecessary mpMRI-guided targeted biopsy
by: Guang Xu, et al.
Published: (2023-01-01)

Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
by: Miriam Campistol, et al.
Published: (2022-05-01)

Prospective evaluation of radical prostatectomy without prior biopsy based on PSA or DRE, mpMRI and PSMA-PET
by: C. Stief, et al.
Published: (2023-11-01)

Multiparametric magnetic resonance imaging (mpMRI): Which variable better predicts extracapsular extension of prostate cancer?
by: M.C. Sighinolfi, et al.
Published: (2020-01-01)

Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer
by: Astrid Børretzen, et al.
Published: (2023-10-01)

Radiomic analysis of T2 and ADC mpMRI images in the diagnosis of clinical significant prostate cancer: An early experience
by: F. Prata, et al.
Published: (2020-07-01)

Radiomic analysis of T2 and ADC mpMRI images in the diagnosis of clinical significant prostate cancer: An early experience
by: F. Prata, et al.
Published: (2020-10-01)

Assessing the value of mpMRI PIRADS lesions in the transitional zone: Analysis of a single center repeat biopsy cohort
by: L. Sarchi, et al.
Published: (2020-01-01)

Focal therapy for localized prostate cancer with mpMRI/US fusion-guided radiofrequency ablation: Oncologic and functional outcomes
by: W. Zhu, et al.
Published: (2020-07-01)

Exploring the efficacy of multi-flavored feature extraction with radiomics and deep features for prostate cancer grading on mpMRI
by: Hasan Khanfari, et al.
Published: (2023-11-01)

Developing a predictive model for clinically significant prostate cancer by combining age, PSA density, and mpMRI
by: Zengni Ma, et al.
Published: (2023-03-01)

Outcomes and predictors of pain in transperineal free-hand mpMRI fusion-targeted biopsies under local anesthesia: A multicenter study of 1,008 patients
by: A. Marquis, et al.
Published: (2020-10-01)

The comparative effectiveness of mpMRI and MRI-guided biopsy vs regular biopsy in a population-based PSA testing: a modeling study
by: Abraham M. Getaneh, et al.
Published: (2021-01-01)

Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI
by: E. J. Her, et al.
Published: (2020-07-01)

mpMRI-US Fusion-Guided Targeted Cryotherapy in Patients with Primary Localized Prostate Cancer: A Prospective Analysis of Oncological and Functional Outcomes
by: Esaú Fernández-Pascual, et al.
Published: (2022-06-01)